Studies raise concerns that taking anemia drugs after chemo may be harmful

02/27/2007 | NYTimes.com

Anemia drugs sold by Amgen, Johnson & Johnson and Roche could be harming some cancer patients instead of helping them, new studies conclude. The drugs are used to treat anemia that results from chemotherapy, but the studies suggest use of those drugs for that purpose may make the cancer worse. Amgen said its anemia drug was safe and effective when used as intended.

View Full Article in:

NYTimes.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Executive Officer
CarePoint Health Plan
Jersey City, NJ
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Director, Compliance - Health Plan Privacy & Security
Kaiser Permanente
Oakland, CA